Delivery Order SPE2DB24D1201-SPE2DB25FJBBD

Award Date 12/31/24
Potential Completion Date 1/2/25
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB25FJBBD
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $29,878.21, is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 2, 2025. This appears to be a one-off delivery order and not part of a larger contract vehicle. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp is the prime contractor, and there are no major subcontractors mentioned. The DLA, a defense agency, is the funding agency for this contract, which supports the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/1/25, 10:52 AM